ARCHIVES

President’s Budget Request for FDA Omits Funding for Critical Path.

This article is from The Cancer Letter archive.

Vol. 34 No. 05 | February 8, 2008

Download PDF Visit The Full Archive

Related Articles

NCI to set separate payline for R01s over $700,000.

February 13, 2004

Biotech Firm Plans Custom Clinical trials In USSR for Drug Firms

August 18, 1989

Basic Biology Progress, Improved Survival Since 1971 Described By DeVita At Senate Hearing

February 27, 1981

FDA Approves Votrient For Soft Tissue Sarcomas

April 27, 2012

Peer Review Study Team Plans Hearing

December 12, 1975

First CCOP 3 Returns In; Payline Not Yet Determined; Goes to NCAB On Jan. 30

January 26, 1990